Stryker M&A Strategy Intact Under New CEO With Latest Deal For Stroke Care
This article was originally published in The Gray Sheet
Executive Summary
Purchase of Surpass Medical for $135 million represents Stryker’s 10th acquisition since 2009. The company affirmed its acquisition strategy focused on core and key adjacent markets during its Oct. 17 earnings call, but also sought to ratchet down earnings growth expectations in the near term to account for headwinds, including the upcoming U.S. medical device excise tax.